Related Experiment Video
Updated: Jun 19, 2026
08:01
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma
Yongping Cai1, Alexander B Mohseny, Marcel Karperien
1Department of Pathology, School of Medicine, Shandong University, Jinan 250012, PR China.
The Journal of Pathology
|November 3, 2009
Summary
The Wnt/beta-catenin pathway is inactivated in most osteosarcoma bone cancers. Activating this pathway inhibits cancer cell growth and promotes bone cell differentiation, suggesting a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Skeletal Development
Background:
- Osteosarcoma, a common bone cancer in adolescents, involves rapid bone growth.
- The Wnt/beta-catenin pathway is vital for skeletal development and osteoblast differentiation.
- Previous studies on Wnt/beta-catenin in osteosarcoma lacked functional validation.
Purpose of the Study:
- To investigate the functional activity of the Wnt/beta-catenin pathway in human osteosarcoma.
- To determine the effect of modulating Wnt/beta-catenin activity on osteosarcoma cell behavior.
Main Methods:
- Immunohistochemistry to assess nuclear beta-catenin in osteosarcoma and osteoblastoma biopsies and cell lines.
- Modulation of Wnt/beta-catenin pathway using a GSK3beta inhibitor (GIN).
- Evaluation of cell proliferation, osteogenic differentiation markers (ALP activity, mineralization), and Wnt-luciferase activity.
Main Results:
- Nuclear beta-catenin was absent in 90% of osteosarcoma samples but present in benign osteoblastomas.
- GIN treatment activated the Wnt/beta-catenin pathway, increasing nuclear beta-catenin and AXIN2 mRNA.
- Wnt/beta-catenin pathway activation inhibited proliferation in MG-63 and U-2-OS cells and enhanced differentiation in HOS and SJSA-1 cells.
Conclusions:
- The Wnt/beta-catenin pathway is functionally inactivated in osteosarcoma.
- Activation of this pathway demonstrates anti-proliferative and pro-differentiation effects in osteosarcoma cells.
- Loss of Wnt/beta-catenin activity may contribute to osteosarcoma pathogenesis, suggesting therapeutic potential.
Related Concept Videos
02:54Canonical Wnt Signaling Pathway
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
02:54Canonical Wnt Signaling Pathway
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
01:41Non-Canonical Wnt Signaling Pathways
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
01:41Non-Canonical Wnt Signaling Pathways
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
01:23Catenins
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...